// App-Quantinova.ai

1174-119 : EFFICACY AND SAFETY OF LOW TO MEDIUM-DOSE VERSUS HIGH-DOSE ASPIRIN AFTER PERCUTANEOUS CORONARY INTERVENTION: EVIDENCE BEYOND THE CURRENT-OASIS 7 TRIAL

Researchers

Presenter

  • Chirag Bavishi

Principal Investigators

  • Vrinda Trivedi

  • Saurav Chatterjee

  • Jacqueline Tamis-Holland

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved